Sirnaomics Ltd. (2257.HK) HKSE

12.62

-0.69(-5.18%)

Updated at October 17 04:08PM

Currency In HKD

Sirnaomics Ltd.

Address

401 Professional Drive

Gaithersburg, MD 20879

Hong Kong

Phone

301 740 1730

Sector

Healthcare

Industry

Biotechnology

Employees

69

First IPO Date

December 30, 2021

Key Executives

NameTitlePayYear Born
Dr. Hung Fai Poon Ph.D.Chief Executive Officer & Executive Director01979
Dr. Yongxiang WangChief Production Officer234,4341953
Dr. David Mark Evans Ph.D.Head of Drug Discovery & Collaboration742,3731963
Dr. Yang Lu Ph.D.Honorary Scientific Scientific Officer2.02M1956
Mr. Yun Ting YuenCompany Secretary01992

Description

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, focuses on the discovery and development of product candidates for indications with medical needs in the United Sates and the People's Republic of China. Its lead product candidates include STP705 for the treatment cutaneous squamous cell carcinoma in situ; basal cell carcinoma; cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; keloid scarless healing, hypertrophic scarring, and fat sculpting. The company's lead product candidates also comprise STP707 to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; metastatic cutaneous squamous cell carcinoma; non-small cell lung cancer; liver fibrosis; and lung fibrosis. It also develops STP355 for the treatment of pan cancer; STP369 to treat head and neck/bladder cancer; STP779 for the treatment of liver/lung/pancreatic cancer; STP902 to treat breast cancer; STP702 for the treatment of influenza; STP908 to treat COVID-19; RIM730 COVID-19 vaccine; STP909 for the treatment of HPV/cervical cancer; and STP122G for thrombotic disorders. In addition, the company is developing STP125G to treat hypertriglyceridemia; STP144G for the treatment of complement-mediated diseases; STP133G for cardiometabolic; and STP155G for the treatment hepatitis B virus. Sirnaomics Ltd. was founded in 2007 and is headquartered in Gaithersburg, Maryland.